Multispectral Fluorescence Imaging Allows for Distinctive Topographic Assessment and Subclassification of Tumor-Infiltrating and Surrounding Immune Cells.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 23 1 2019
pubmed: 23 1 2019
medline: 15 6 2019
Statut: ppublish

Résumé

Histomorphology has significantly changed over the last decades due to technological achievements in immunohistochemistry (IHC) for the visualization of specific proteins and in molecular pathology, particularly in the field of in situ hybridization of small oligonucleotides and amplification of DNA and RNA amplicons. With an increased availability of suitable methods, the demands regarding the observer of histomorphological slides were the supply of complex quantitative data as well as more information about protein expression and cell-cell interactions in tissue sections. Advances in fluorescence-based multiplexed IHC techniques, such as multispectral imaging (MSI), allow the quantification of multiple proteins at the same tissue section. In histopathology, it is a well-known technique for over a decade yet harboring serious problems concerning quantitative preciseness and tissue autofluorescence of multicolor staining when using formalin-fixed, paraffin-embedded (FFPE) tissue specimen. In recent years, milestones in tissue preparation, fluorescent dyes, hardware imaging, and software analysis were achieved including automated tissue segmentation (e.g., tumor vs. stroma) as well as in cellular and subcellular multiparameter analysis.This chapter covers the role that MSI plays in anatomic pathology for the analysis of FFPE tissue sections, discusses the technical aspects of MSI, and provides a review of its application in the characterization of immune cell infiltrates and beyond regarding its prognostic and predictive value and its use for guidance of clinical decisions for immunotherapeutic strategies.

Identifiants

pubmed: 30666596
doi: 10.1007/978-1-4939-8979-9_2
doi:

Substances chimiques

Antineoplastic Agents, Immunological 0
Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-31

Auteurs

Claudia Wickenhauser (C)

Medical Faculty, Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Daniel Bethmann (D)

Medical Faculty, Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Zipei Feng (Z)

Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

Shawn M Jensen (SM)

Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

Carmen Ballesteros-Merino (C)

Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

Chiara Massa (C)

Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Andre Steven (A)

Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Marcus Bauer (M)

Medical Faculty, Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Peter Kaatzsch (P)

Medical Faculty, Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Nikolaos Pazaitis (N)

Medical Faculty, Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Georgiana Toma (G)

Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Carlo B Bifulco (CB)

Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

Bernard A Fox (BA)

Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA.

Barbara Seliger (B)

Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. barbara.seliger@uk-halle.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH